Cargando...
Lipid lowering and Alzheimer disease risk: A mendelian randomization study
OBJECTIVE: To examine whether genetic variation affecting the expression or function of lipid‐lowering drug targets is associated with Alzheimer disease (AD) risk, to evaluate the potential impact of long‐term exposure to corresponding therapeutics. METHODS: We conducted Mendelian randomization anal...
Gardado en:
| Publicado en: | Ann Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944510/ https://ncbi.nlm.nih.gov/pubmed/31714636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25642 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|